Hepatocellular carcinoma

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 2, 2015, Pages

  Buendia, Marie Annick ^a   Neuveut, Christine ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS DNA;

ARTICLE; CARCINOGENESIS; CHROMOSOME; DNA INTEGRATION; EPIGENETICS; GENOME; GENOMIC INSTABILITY; GENOMICS; HEPADNAVIRUS; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HOST CELL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER REGENERATION; MUTAGENESIS; NONHUMAN; PATHOGENESIS; TUMOR GENE; ANIMAL; DISEASE MODEL; GENETICS; LIVER TUMOR; MARMOTA; MOUSE; ONCOGENE; TRANSGENIC MOUSE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION; WOODCHUCK HEPATITIS VIRUS;

HEPATITIS B VIRUS;

ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B VIRUS, WOODCHUCK; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MARMOTA; MICE; MICE, TRANSGENIC; ONCOGENES; TRANS-ACTIVATORS; VIRUS INTEGRATION;

EID: 84923798820     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a021444     Document Type: Article

References (72)

1. Beasley RP, Lin CC, Hwang LY, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 2: 1129-1133.
2. Benhenda S, Cougot D, Buendia MA, Neuveut C. 2009. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 103: 75-109.
3. Bouchard MJ, Schneider RJ. 2004. The enigmatic X gene of hepatitis B virus. J Virol 78: 12725-12734.
4. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouis-sou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D,et al. 2007. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45: 42-52.
5. Bréchot C, Pourcel C, Louise A, Rain B, Tiollais P. 1980. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286: 533-535.
6. Bruni R, D’Ugo E, Giuseppetti R, Argentini C, Rapicetta M. 1999. Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. Virology 257: 483-490.
7. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, REVEAL-HBV Study Group. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
8. Dejean A, Sonigo P, Wain-Hobson S, Tiollais P. 1984. Spe-cific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11 base pair direct repeat. Proc Natl Acad Sci 81: 5350-5354.
9. El-Serag HB. 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 1264-1273.
10. Etiemble J, Degott C, Renard CA, Fourel G, Shamoon B, Vitvitski-Trepo L, Hsu TY, Tiollais P, Babinet C, Buendia MA. 1994. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 9: 727-737.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
12. Fletcher SP, Chin DJ, Ji Y, Iniguez AL, Taillon B, Swinney DC, Ravindran P, Cheng DT, Bitter H, Lopatin U, et al. 2012. Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology 56: 820-830.
13. Forner A, Llovet JM, Bruix J. 2012. Hepatocellular carcinoma. Lancet 379: 1245-1255.
14. Fourel G, Trépo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA. 1990. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347: 294-298.
15. Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P, Buendia MA. 1994. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J 13: 2526-2534.
16. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al. 2012. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44: 760-764.
17. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, et al. 2012. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44: 694-698.
18. Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. 2013. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 144: 512-527.
19. Hino O, Ohtake K, Rogler CE. 1989. Features of two heap-titis B virus (HBV) DNA integrations suggest mecha-nisms of HBV integration. J Virol 63: 2638-2643.
20. Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, et al. 2013. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 58: 98-107.
21. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, et al. 2009. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69: 7385-7392.
22. Hsu T, Moroy T, Etiemble J, Louise A, Trepo C, Tiollais P, Buendia MA. 1988. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55: 627-635.
23. Jacob JR, Sterczer A, Toshkov IA, Yeager AE, Korba BE, Cote PJ, Buendia MA, Gerin JL, Tennant BC. 2004. Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors. Hep-atology 39: 1008-1016.
24. Jiang Z, Jhunjhunwala S, Liu J, Haverty PM, Kennemer MI, Guan Y, Lee W, Carnevali P, Stinson J, Johnson S, et al. 2012. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res 22: 593-601.
25. Kaposi-Novak P, Libbrecht L, Woo HG, Lee YH, Sears NC, Conner EA, Factor VM, Roskams T, Thorgeirsson SS. 2009. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 69: 2775-2782.
26. Kim CM, Koike K, Saito I, Miyamura T, Jay G. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320.
27. Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H, Gerin JL. 1989. Hepatocellular carcinoma in wood-chuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 9: 461-470.
28. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS. 2004. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40: 667-676.
29. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, et al. 2011. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43: 828-829.
30. Li X, Zhang J, Yang Z, Kang J, Jiang S, Zhang T, Chen T, Li M, Lv Q, Chen X, et al. 2014. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma. J Hepatol 60: 975-984.
31. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. 2009. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis. J Natl Cancer Inst 101: 1066-1082.
32. Longato L, de la Monte S, Kuzushita N, Horimoto M, Rog-ers AB, Slagle BL, Wands JR. 2009. Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology 49: 1935-1943.
33. Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bern-heim A, Dejean A. 2000. Distinct chromosomal abnor-mality pattern in primary liver cancer of non-B, non-C patients. Oncogene 19: 3733-3738.
34. Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci 77: 2941-2945.
35. Martin-Lluesma S, Schaeffer C, Robert EI, van Breugel PC, Leupin O, Hantz O, Strubin M. 2008. Hepatitis B virus X protein affects S phase progression leading to chromo-some segregation defects by binding to damaged DNA binding protein 1. Hepatology 48: 1467-1476.
36. Mason WS. 2015. Animal modes and the molecular biology of hepadnavirus infection. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021352.
37. Mason WS, Jilbert AR, Summers J. 2005. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc Natl Acad Sci 102: 1139-1144.
38. Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C, Paterlini-Brechot P. 2005. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54: 1162-1168.
39. Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T, Kamino K, Yamamura K, Matsubara K. 1987. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1: 773-782.
40. Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J. 2013. High frequency of telomerase reverse-tran-scriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 4: 2218.
41. Neuveut C, Wei Y, Buendia MA. 2010. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52: 594-604.
42. Ott JJ, Stevens GA, Groeger J, Wiersma ST. 2012. Global epidemiology of hepatitis B virus infection: New esti-mates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 2212-2219.
43. Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. 2004. Infectious agents and cancer: Criteria for a causal relation. Semin Cancer Biol 14: 453-471.
44. Pollicino T, Cacciola I, Saffioti F, Raimondo G. 2014. Hep-atitis B virus PreS/S gene variants: Pathobiology and clinical implications. J Hepatol 61: 408-417.
45. Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL. 1987. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci 84: 866-870.
46. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, et al. 2008. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49: 652-657.
47. Renard CA, Fourel G, Bralet MP, Degott C, De la Coste A, Perret C, Tiollais P, Buendia MA. 2000. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: Oncogenic mutations of b-catenin and synergistic effects of p53 null alleles. Oncogene 19: 2678-2686.
48. Rogler CE, Summers J. 1984. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J Virol 50: 832-837.
49. Scaglione SJ, Lok AS. 2012. Effectiveness of hepatitis B treat-ment in clinical practice. Gastroenterology 142: 1360-1368.
50. Shafritz DA, Shouval D, Sherman H, Hadziyannis S, Kew MC. 1981. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepato-cellular carcinoma. New Engl J Med 305: 1067-1073.
51. Shlomai A, de Jong YP, Rice CM. 2014. Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol 26C: 78-88.
52. Slagle BL, Bouchard MJ. 2015. Regulation of viral gene expression. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021402.
53. Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS. 1996. Increased sensitivity to the hepatocarcinogen diethylni trosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 15: 261-269.
54. Studach L, Wang WH, Weber G, Tang J, Hullinger RL, Mal-brue R, Liu X, Andrisani O. 2010. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. J Biol Chem 285: 30282-30293.
55. Summers J, Smolec JM, Snyder R. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci 75: 4533-4537.
56. Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, et al. 2012. Genome wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44: 765-769.
57. Szmuness W. 1978. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 24: 40-69.
58. Takada S, Koike K. 1990. Trans-activation function of a 30 truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci 87: 5628-5632.
59. Tamori A, Yamanishi Y, Kawashima S, Kanehisa M, Eno-moto M, Tanaka H, Kubo S, Shiomi S, Nishiguchi S. 2005. Alteration of gene expression in human hepatocel-lular carcinoma with integrated hepatitis B virus DNA. Clin Cancer Res 11: 5821-5826.
60. Tang H, Oishi N, Kaneko S, Murakami S. 2006. Molecular functions and biological roles of hepatitis B virus X pro tein. Cancer Sci 97: 977-983.
61. Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Horn-buckle WE, Schinazi RD, Korba BE, Cote PJ, Gerin JL. 2004. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology 127: S283-S293.
62. Terradillos O, Billet O, Renard CA, Lévy R, Molina T, Briand P, Buendia MA. 1997. The hepatitis B virus X gene po tentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14: 395-404.
63. Toh ST, Jin Y, Liu L, Wang J, Babrzadeh F, Gharizadeh B, Ronaghi M, Toh HC, Chow PK, Chung AY, et al. 2013. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Carcino-genesis 34: 787-798.
64. Villanueva A, Llovet JM. 2014. Liver cancer in 2013: Muta-tional landscape of HCC-The end of the beginning. Nat Rev Clin Oncol 11: 73-74.
65. Wang J, Chenivesse X, Henglein B, Bréchot C. 1990. Hepa-titis B virus integration in a cyclin A gene in a human hepatocellular carcinoma. Nature 343: 555-557.
66. Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, Wang D, Sun Y, Hu G, Lang Z, et al. 2004. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 39: 318-324.
67. Wei Y, Fourel G, Ponzetto A, Silvestro M, Tiollais P, Buendia MA. 1992. Hepadnavirus integration: Mechanisms of ac tivation of the N-myc2 retrotransposon in woodchuck liver tumors. J Virol 66: 5265-5276.
68. Wen Y, Golubkov VS, Strongin AY, Jiang W, Reed JC. 2008. Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mi-totic spindle formation. J Biol Chem 283: 2793-2803.
69. Wu CY, Lin JT, Ho HJ, Su CW, Lee TY, Wang SY, Wu C, Wu JC. 2014. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B-A nationwide cohort study. Gastroenterology 147: 143-151.
70. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, et al. 2008. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134-1143.
71. Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK. 2011. Risk esti mation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predict-tive score. Lancet Oncol 12: 568-574.
72. Zoulim F. 2012. Are novel combination therapies needed for chronic hepatitis B? Antiviral Res 96: 256-259.